1-3 of 3
Yiwei Li
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Novel Combination of Clinical Menin Inhibitor Ziftomenib and the Nuclear Export Inhibitor Selinexor Synergistically Inhibit MLL-r AML

Free
Md. Hafiz Uddin, Amro Aboukameel, Husain Khan, Sahar Bannoura, Yiwei Li, Abhinav Deol, Jay Yang, Asfar Sohail Azmi, Jaroslaw P. Maciejewski, Suresh Kumar Balasubramanian
Journal: Blood
Blood (2022) 140 (Supplement 1): 8811–8812.
https://doi.org/10.1182/blood-2022-168151
Published: 2022
Journal Articles

Dual Targeting PAK4 and NAMPT As a Novel Therapeutic Approach for Aggressive Non-Hodgkin's Lymphoma

Free
Suresh Kumar Balasubramanian, Husain Khan, Md. Hafiz Uddin, Amro Aboukameel, Yiwei Li, Jeffrey A. Zonder, William T. Senapedis, Jr., Erkan Baloglu, Ramzi Mohammad, Jatin J. Shah, Yosef Landesman, Sharon Shacham, Michael G. Kauffman, Asfar Sohail Azmi
Journal: Blood
Blood (2021) 138 (Supplement 1): 683.
https://doi.org/10.1182/blood-2021-145615
Published: 2021
Journal Articles

Selinexor in Combination with R-CHOP for Frontline Treatment of Non-Hodgkin Lymphoma: Results of a Phase 1b Study

Free
Erlene K. Seymour, MD, Yiwei Li, Amro Aboukameel, Radhakrishnan Ramchandren, Golbon Sterbis, Jay Yang, MD, Divaya Bhutani, MD, Ramzi Mohammad, PhD, Asfar Sohail Azmi, PhD, Jeff Zonder, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 11–12.
https://doi.org/10.1182/blood-2020-140752
Published: 2020